Treatment Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in naïve Chronic Hepatitis B

CompletedOBSERVATIONAL
Enrollment

572

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

October 31, 2018

Study Completion Date

October 31, 2018

Conditions
Chronic Hepatitis B
Interventions
DRUG

tenofovir disoproxil fumarate

Trial Locations (1)

Unknown

The Catholic University of Korea, Daejeon St.Mary's Hosptial, Junggu

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Gilead Sciences

INDUSTRY

collaborator

Wonkwang University

OTHER

collaborator

Soonchunhyang University Hospital

OTHER

collaborator

Chungnam National University Hospital

OTHER

collaborator

Konyang University Hospital

OTHER

lead

Myeong Jun Song

OTHER